Med-Tech Innovation July 9, 2024
Endoron Medical (“Endoron”), a pioneering medtech company specialising in innovative endograft stapling solutions for the endovascular repair of abdominal aortic aneurysms, announced the successful closing of its 10 million USD Series A funding round. The round was led by Sofinnova Partners, with significant matching contributions from the European Innovation Council Fund (EIC Fund).
The capital received will accelerate the clinical validation of Endoron’s flagship product, the catheter-based EndoStapling solution Aortoseal, as it progresses through its Investigational Device Exemption (IDE) approved Early Feasibility Study (EFS).
“Sofinnova Partners are the go-to investors within medtech. They bring a wealth of operational experience working with high-growth companies like ours,” said Ronit Harpaz, co-founder and CEO of Endoron. “With their continued support, I am confident...
Today's Sponsors
Today's Sponsor